These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7747578)

  • 1. Ocular effects and systemic absorption of cyclopentolate eyedrops after canthal and conventional application.
    Lahdes KK; Huupponen RK; Kaila TJ
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):698-702. PubMed ID: 7747578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic absorption of ocular cyclopentolate in children.
    Lahdes K; Huupponen R; Kaila T; Ali-Melkkilä T; Salminen L; Saari M
    Ger J Ophthalmol; 1992; 1(1):16-8. PubMed ID: 1477610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Clinical Randomized Trial Comparing the Cycloplegic Effect of Cyclopentolate Drops Applied to Closed Eyelids Versus Open Eyelids.
    Zurevinsky J; Sawchuk K; Lim HJ; Lee CH; Rubab S
    Am Orthopt J; 2016 Jan; 66(1):114-121. PubMed ID: 27799585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations and ocular effects of cyclopentolate after ocular application of three formulations.
    Lahdes K; Huupponen R; Kaila T; Monti D; Saettone MF; Salminen L
    Br J Clin Pharmacol; 1993 May; 35(5):479-83. PubMed ID: 8512760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the time interval between instillation of two drops of cyclopentolate 1% on refraction and dilation of the pupil in children.
    Stolovitch C; Alster Y; Loewenstein A; Lazar M
    Am J Ophthalmol; 1995 May; 119(5):637-9. PubMed ID: 7733189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and ocular absorption and antagonist activity of topically applied cyclopentolate in man.
    Haaga M; Kaila T; Salminen L; Ylitalo P
    Pharmacol Toxicol; 1998 Jan; 82(1):19-22. PubMed ID: 9527641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a pediatric cycloplegic administered as a spray.
    Bartlett JD; Wesson MD; Swiatocha J; Woolley T
    J Am Optom Assoc; 1993 Sep; 64(9):617-21. PubMed ID: 8227937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of cyclopentolate 1% to the medial canthus in children.
    Stolovitch C; Alster Y; Goldstein M; Loewenstein A; Lazar M
    J Pediatr Ophthalmol Strabismus; 1998; 35(3):182-4. PubMed ID: 9627884
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic absorption of ophthalmic cyclopentolate.
    Kaila T; Huupponen R; Salminen L; Iisalo E
    Am J Ophthalmol; 1989 May; 107(5):562-4. PubMed ID: 2712146
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse reactions to 1% cyclopentolate eye drops in children: an analysis using logistic regression models.
    Imai T; Hasebe S; Furuse T; Morisawa S; Hasebe K; Nagata Y; Tokutake T; Moriyama Y
    Ophthalmic Physiol Opt; 2021 Mar; 41(2):424-430. PubMed ID: 33300632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of the instillation of two versus three eyedrops of cyclopentolate 0.5% on refraction of Caucasian nonstrabismic children].
    Gadioux-Madern F; Lelez ML; Sellami L; Santallier M; Fourquet F; Pisella PJ; Arsene S
    J Fr Ophtalmol; 2008 Jan; 31(1):51-5. PubMed ID: 18401299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects on accommodative and pupillary responses by topical application of cyclopentolate hydrochloride].
    Ohmi G; Kinoshita H; Kinoshita S
    Nippon Ganka Gakkai Zasshi; 1991 Nov; 95(11):1099-104. PubMed ID: 1759650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of some macromolecular ionic complexes on the pharmacokinetics and -dynamics of ocular cyclopentolate in rabbits.
    Huupponen R; Kaila T; Saettone MF; Monti D; Ilsalo E; Salminen L; Oksala O
    J Ocul Pharmacol; 1992; 8(1):59-67. PubMed ID: 1402295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of drop instillation and spray application of 1% cyclopentolate hydrochloride.
    Ismail EE; Rouse MW; De Land PN
    Optom Vis Sci; 1994 Apr; 71(4):235-41. PubMed ID: 8047334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1% Cyclopentolate hydrochloride: another look at the time course of cycloplegia using an objective measure of the accommodative response.
    Manny RE; Fern KD; Zervas HJ; Cline GE; Scott SK; White JM; Pass AF
    Optom Vis Sci; 1993 Aug; 70(8):651-65. PubMed ID: 8414387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mydriatic efficacy of a cycloplegic spray in the pediatric population.
    Wesson MD; Bartlett JD; Swiatocha J; Woolley T
    J Am Optom Assoc; 1993 Sep; 64(9):637-40. PubMed ID: 8227938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children.
    Ebri A; Kuper H; Wedner S
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1025-31. PubMed ID: 17325142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eyedrop instillation for reluctant children.
    Smith SE
    Br J Ophthalmol; 1991 Aug; 75(8):480-1. PubMed ID: 1873267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a Cycloplegic Agent Administered as a Spray in the Pediatric Population.
    Vagge A; Del Noce C; Pellegrini M; Cappelli F; Musolino M; Bernabei F; Giannaccare G; Traverso CE
    J Pediatr Ophthalmol Strabismus; 2020 Sep; 57(5):301-304. PubMed ID: 32956479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of eye drops to the medial canthus.
    Loewenstein A; Bolocinic S; Goldstein M; Lazar M
    Graefes Arch Clin Exp Ophthalmol; 1994 Nov; 232(11):680-2. PubMed ID: 7843594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.